halotag® fusion proteins (Promega)
90
Structured Review
Promega
halotag® fusion proteins
Halotag® Fusion Proteins, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/halotag%C2%AE+fusions/halotag+protein/pmc12107431-63-27-40
Average 90 stars, based on 1 article reviews
Halotag® Fusion Proteins, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/halotag%C2%AE+fusions/halotag+protein/pmc12107431-63-27-40
Average 90 stars, based on 1 article reviews
halotag® fusion proteins - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex"
Article Title: The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkaf439
Figure Legend Snippet: In-cell binding analysis between ETO2 and the GATAD2A (M) PPPL region. ( A ) A diagram depicts the different NanoLuc (NL) and HaloTag (HT) constructs for binding analysis by bioluminescence resonance energy transfer (NanoBRET). Six different ( M )PPPL constructs were designed, including two with the NL donor tag on the C -termini (one including the neighboring CR1 domain as a coiled-coil single chain sequence on the N -terminus, see Materials and methods). The remaining four ( M )PPPL constructs contain the NL tag on the N -terminus to allow for C -terminal truncation while maintaining the same relative position of the NL tag. Three ETO2 C -terminal HT constructs were designed to maintain the same relative position of the HT acceptor tag. ( B ) The interaction between ETO2-NHR4 and sc ( M )PPPLx4 yields a strong BRET intensity, which progressively increases with the inclusion of the NHR3 and NHR2 domains. Mutating the key tryptophan residue that interacts with the first proline of the PPPL motif (M585A) markedly decreases the BRET signal with all ETO2-HT constructs. ( C ) Truncating the PPPLx4 progressively reduces the observed BRET signal. ( D ) Introducing mutations to the ETO2-NHR2 tetramerization domain that disrupt tetramerization (M7) or dimerization (M5) decreases the BRET signal intensity ( P values reflect a comparison with the equivalent wild-type interaction). ( E ) A diagram shows the M5 and M7 mutations in the ETO2-NHR2 tetramerization domain. All measurements were performed in quadruplicate and repeated at least twice to confirm the results. P -values (<0.05=* and <0.01=**) were determined by the Student’s T-test with Welch’s correction.
Techniques Used: Binding Assay, Construct, Bioluminescence Resonance Energy Transfer, Sequencing, Residue, Comparison
Related Articles
Purification:Article Title: Substituted imidazo[1,2-a]pyrazines for use in bioluminogenic methods Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: To further examine inhibition resistance, purified 9B8 and L27V were screened against various concentrations of Suramin (Sigma S-2671) and Tyrphostin AG 835 (“Tyr ag 835”) (Sigma T-5568) (FIGS. 52A-C). Article Title: Methylation specific targeting of a chromatin remodeling complex from sponges to humans Article Snippet: The coiled-coil domains of HsMBD2 (amino acids 360–392) and EmMBD2/3a (amino acids 324–354) were cloned into the pHTN and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Protein Purification:Article Title: Substituted imidazo[1,2-a]pyrazines for use in bioluminogenic methods Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: To further examine inhibition resistance, purified 9B8 and L27V were screened against various concentrations of Suramin (Sigma S-2671) and Tyrphostin AG 835 (“Tyr ag 835”) (Sigma T-5568) (FIGS. 52A-C). Article Title: Methylation specific targeting of a chromatin remodeling complex from sponges to humans Article Snippet: The coiled-coil domains of HsMBD2 (amino acids 360–392) and EmMBD2/3a (amino acids 324–354) were cloned into the pHTN and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Clone Assay:Article Title: Substituted imidazo[1,2-a]pyrazines for use in bioluminogenic methods Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: To further examine inhibition resistance, purified 9B8 and L27V were screened against various concentrations of Suramin (Sigma S-2671) and Tyrphostin AG 835 (“Tyr ag 835”) (Sigma T-5568) (FIGS. 52A-C). Article Title: Methylation specific targeting of a chromatin remodeling complex from sponges to humans Article Snippet: The coiled-coil domains of HsMBD2 (amino acids 360–392) and EmMBD2/3a (amino acids 324–354) were cloned into the pHTN and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Expressing:Article Title: Substituted imidazo[1,2-a]pyrazines for use in bioluminogenic methods Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: To further examine inhibition resistance, purified 9B8 and L27V were screened against various concentrations of Suramin (Sigma S-2671) and Tyrphostin AG 835 (“Tyr ag 835”) (Sigma T-5568) (FIGS. 52A-C). Article Title: Methylation specific targeting of a chromatin remodeling complex from sponges to humans Article Snippet: The coiled-coil domains of HsMBD2 (amino acids 360–392) and EmMBD2/3a (amino acids 324–354) were cloned into the pHTN and Article Title: Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use Article Snippet: 9B8 and L27V variants were expressed as N-terminal HALOTAG® fusions (pFN18K for E. coli; pFN21K for HEK293 cells) in HEK293 and |